@article {65, title = {Retraction notice}, journal = {Journal of Pharmacy Practice and Community Medicine}, volume = {7}, year = {2021}, month = {December 2021}, pages = {51}, type = {Retraction notice}, chapter = {51}, abstract = {

The research article entitled {\textquotedblleft}Incidence and Assessment of Adverse Drug Reactions at a Tertiary Care Hospital{\textquotedblright} by Priyanka et al., Journal of Pharmacy Practice and Community Medicine. 2020;6(1). DOI:10.5530/jppcm.2020.1.5[1] is retracted.

After the above article was published, one of the readers reported that the authors had published the same article in the World Journal of Pharmaceutical Research. 2017 Aug 6;6(12):967-8.[2]

The Journal of Pharmacy Practice and Community Medicine (JPPCM) journal further investigated the publication in the World Journal of Pharmaceutical Research and found that the afore mentioned manuscript was self-plagiarized with a same title. The corresponding author and others of the manuscript was contacted by JPPCM journal for clarification, and they responded it is unknowingly plagiarised.

The JPPCM journal editors have further investigated and thus agreed that Priyanka et al., violated the journal policy and the self-plagiarized manuscript be retracted from the JPPCM website. JPPCM{\textquoteright} decision will be communicated to the corresponding author of the manuscript Priyanka et al., and others, INDIA.

Akram Ahmad, PhD Editor-in-Chief, Journal of Pharmacy Practice and Community Medicine.

}, author = {Akram Ahmad} } @article {68, title = {Retraction Notice}, journal = {Journal of Pharmacy Practice and Community Medicine}, volume = {7}, year = {2021}, month = {March 2022}, pages = {59}, type = {Retraction Notice}, chapter = {59}, abstract = {

The research article entitled {\textquotedblleft}Vannala V, Balachandar, Kumaran K, Sigamani R. Biofilm formation on polytetrafluoroethylene coated versus uncoated brackets in a South Indian Population. Journal of Pharmacy Practice and Community Medicine. 2017;3(3):188-90. doi:10.5530/jppcm.2017.3.38 is retracted.[1] JPPCM received an email from the corresponding author, who asked if there was a way to edit or amend or withdraw the article that was previously published in JPPCM. The corresponding author and other authors of the manuscript were contacted by the JPPCM for clarification, and they stated that {\textquotedblleft}By mistake, a portion of the literature review content was added in the result sections of the abstract as well as the text which was overlooked by us, and by mistake, it remained in our manuscript and got published.{\textquotedblright} The JPPCM journal editors agreed with authors{\textquoteright} decision and decided the manuscript to be retracted from the JPPCM website. JPPCM decision will be communicated to the corresponding author of the manuscript Sigamani et al., INDIA.

}, author = {Akram Ahmad} } @article {27, title = {Fecal-Oral Transmission of COVID-19 in India}, journal = { Journal of Pharmacy Practice and Community Medicine}, volume = {6}, year = {2020}, month = {June 2020}, pages = {18-19}, type = {Editorial}, chapter = {18}, abstract = {

Although the spread of COVID-19 through droplets, surface contact and aerosolized transmission has been well-publicized, the fecal-oral route is yet another identified method of transmission. According to a meta-analysis by the New England Journal of Medicine, it was found that fecal viral shedding continues throughout the disease, even after nasopharyngeal tests appear negative. Moreover, gastrointestinal symptoms seem to be common for COVID-19 patients, with a prevalence of approximately 18\%.[1,2] It was also found that patients with digestive symptoms experience significantly longer hospital stays.[3] As India{\textquoteright}s number of COVID-19 cases continues to increase, concerns about fecal-oral transmission are being raised in a country that has the highest open defecation rates in the world, where approximately 620 million people defecate in the open. It is a problem that comes with severe public health consequences, including diarrhea, high child mortality, spread of diseases, malnutrition and stunting of growth.[4] Public health officials should be concerned about how this will affect India{\textquoteright}s transmission of COVID-19. Read more.....

}, keywords = {Nil}, doi = {10.5530/jppcm.2020.2.6}, author = {Allyson Goff and Akram Ahmad and Isha Patel} } @article {30, title = {To Suppress or to Mitigate COVID-19: That is the Question}, journal = {Journal of Pharmacy Practice and Community Medicine}, volume = {6}, year = {2020}, month = {June 2020}, pages = {20-21}, type = {Editorial}, chapter = {20}, abstract = {

In India, public health experts have been debating the most effective way of combating COVID-19 (or SARS-COV-2 virus) while balancing the amount of lives lost and trying to preserve the economy. This virus is particularly challenging for India as the population is so large, and the healthcare system is still developing to meet the needs of its citizens. While social distancing has been and is being widely practiced worldwide to mitigate the further spread of COVID-19, it is apparent that more aggressive public health measures are needed to further decrease the numbers of infected people. Already, India has extended its lockdown from March 24th to the end of May.[1] By better understanding how this virus propagates, as well as by considering the unique needs of India, experts can better determine the best measures to fight further spread. Read more.....

}, keywords = {Nil}, doi = {10.5530/jppcm.2020.2.7}, author = {Anam Khan and Allyson Goff and Akram Ahmad and Isha Patel} }